Tracheobronchopathy From Inhaled Corticosteroids

Chest. 2017 Dec;152(6):1296-1305. doi: 10.1016/j.chest.2017.08.013. Epub 2017 Aug 31.

Abstract

Inhaled corticosteroids (ICSs) have become the mainstay of asthma control. They are also recommended as an add-on therapy to long-acting beta agonists and anticholinergics in moderate to severe COPD with recurrent exacerbations. Ultimately this clinical practice has led to the widespread use of ICSs, which are supported by a more favorable side effect profile than that of systemic steroids.

Keywords: excessive dynamic airway collapse; inhaled corticosteroids; tracheobronchomalacia; tracheomalacia.

Publication types

  • Review

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects*
  • Asthma / drug therapy*
  • Bronchial Diseases / chemically induced*
  • Humans
  • Tracheal Diseases / chemically induced*

Substances

  • Adrenal Cortex Hormones